PAGB Digital Week, Day 2: Real-World Evidence And Its Potential In Consumer Healthcare

Day two of PAGB's Digital Week explored potential applications for real world evidence in the consumer healthcare industry, such as generating new claims for established products and to help support prescription-to-OTC switches.

• Source: PAGB

The first session of the day was opened by the PAGB’s acting senior regulatory manager, Christina Gkouva, who presented the association’s latest guidance on the use of real-world data (RWD) and evidence (RWE) in relation to self-care products.

RWD/E had been used in the Rx side of the pharmaceutical industry for a while now, Gkouva pointed out, but...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from United Kingdom

Perrigo Adds High-Strength Paracetamol To UK Solpadeine Line

 
• By 

Perrigo aims its new SolpaOne high-strength paracetamol effervescent at UK pharmacists, who now have expanded powers as part of the UK government's Pharmacy First initiative. 

Can Creatine Supplementation Improve Cognitive Function? No, Says UK Health Claims Committee

 
• By 

Germany's Alzchem failed to convince the UK's health claims committee that daily creatine supplementation can contribute to improved cognitive function. 

People On The Move At Galenica, Haleon, Alliance Pharma

 
• By 

A round-up of the latest moves in Europe's consumer health industry: Galenica names head of new Products & Home Care business unit; Haleon appoints general counsel; Alliance Pharma eliminates COO role.

Infographic: Mental Health, Menopause And Weight Loss Ads Targeted By ASA's AI Monitoring System

 
• By 

Consumer health, particularly food supplements that make unauthorized medical or health claims, has been a key area of focus for the UK Advertising Standards Authority's recently introduced Active Ad Monitoring system, which captures ads by relevant advertisers from a range of social media platforms, and applies machine learning algorithms to identify and flag likely non-compliant ads, which are then sent to experts to review and act on. This infographic highlights recent ASA rulings against ads for supplements claiming to treat anxiety and stress, menopause, autism/ADHD and weight loss, which were flagged by AI.

More from Europe

Navamedic Benefits From Eroxon Launch In Nordics

 
• By 

OTC erectile dysfunction treatment Eroxon has made it to the Nordics through local distributor Navamedic, which has reported strong consumer uptake.

People On The Move: Appointments At Nestlé, Ascendis Health, Be-sup

 
• By 

A round-up of the latest global health and wellness moves: Nestlé and Dr Reddy's name JV head; Be-sup hires comms and regulatory director; Ascendis Health appoints interim CFO.

Perrigo’s Consumer Health Brand Talk Gets An Executive Voice With First Brand Chief Appointed

 

David Ball moves from Bayer’s North America business to be Perrigo’s first chief brand and digital officer. He joins CEO who also moved to Perrigo from Bayer with decades of branded product experience.